Hormone Medicine: How Signal-Based Diagnostics Identify Root Causes
By Kenton Gray, Founder & Chief Executive Officer Read time: 12 minutes
Hormone medicine addresses the biological signals that regulate metabolism, reproduction, stress response, and cellular function. These chemical messengers coordinate every physiological process in your body through feedback loops that conventional medicine rarely measures with sufficient precision. When hormone signaling becomes dysregulated, symptoms appear across multiple systems. Fatigue, weight gain, mood instability, sleep disruption, and cognitive decline are not separate conditions requiring separate treatments. They are downstream manifestations of upstream signal dysfunction.
At Kure Health, we approach hormone dysfunction through Signal-Based Medicine™. This methodology identifies the biological signals driving your symptoms rather than managing the symptoms themselves. Standard hormone panels ordered at annual physicals measure 3-5 markers. Our KureBioMap™ Signal System Mapping evaluates over 14,000 data points across 183 genes and 15 metabolic pathways. What we consistently find: measurable dysfunction in thyroid conversion, insulin signaling, cortisol metabolism, and sex hormone synthesis that exists years before conventional diagnostic thresholds are crossed.
What Hormone Medicine Actually Treats
Hormone medicine corrects signaling dysfunction at the cellular level. Your endocrine system produces chemical messengers that bind to receptors on target cells and trigger specific biological responses. Thyroid hormone regulates metabolic rate. Insulin controls glucose uptake. Cortisol modulates stress response and immune function. Estrogen and testosterone influence tissue growth, bone density, and cognitive function. When these signals become disrupted, the body cannot maintain homeostasis.
The disruption occurs through multiple mechanisms. Receptor sensitivity declines when cells are chronically exposed to elevated hormone levels. Conversion enzymes become inhibited by inflammation, nutrient deficiencies, or toxic burden. Binding proteins increase in response to liver dysfunction, rendering hormones biologically inactive despite normal serum levels. Feedback loops malfunction when the hypothalamic-pituitary axis receives conflicting signals from peripheral tissues.
Dr. Peter F. Demitry, DO, MPH, Former Assistant Air Force Surgeon General for Modernization, implemented Signal-Based diagnostic protocols across military medical facilities and documented a 43% reduction in chronic disease progression among service members when upstream hormone dysfunction was identified and corrected before symptomatic disease manifested. His work established that early intervention at the signal level prevents the cascade of metabolic dysfunction that conventional medicine treats as separate diseases.
How Conventional Medicine Misses Hormone Dysfunction
Conventional hormone assessment uses reference ranges designed to identify pathology, not dysfunction. Your thyroid-stimulating hormone (TSH) must exceed 4.5-5.0 mIU/L before most physicians diagnose hypothyroidism. Yet metabolic symptoms appear when TSH rises above 2.5. Free T3, the active thyroid hormone that enters cells and regulates mitochondrial function, is rarely measured. Reverse T3, the inactive metabolite that blocks thyroid receptors and creates functional hypothyroidism despite normal TSH, is almost never assessed.
Insulin resistance develops over years before fasting glucose becomes elevated. Fasting insulin above 5 µIU/mL indicates early insulin resistance. HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) above 1.5 demonstrates significant metabolic dysfunction. Most annual physicals measure neither. Hemoglobin A1c, the standard diabetes screening tool, detects average glucose levels over 90 days. It identifies disease after years of progressive dysfunction.
Sex hormone assessment in conventional medicine consists of total testosterone or total estrogen measurements. These numbers reveal almost nothing about biological activity. Sex hormone-binding globulin (SHBG) binds circulating testosterone and estrogen, rendering them inactive. Free hormone levels, the fraction available to bind receptors and produce biological effects, require calculated or directly measured assessment. Estrogen metabolism through 2-hydroxy, 4-hydroxy, and 16-hydroxy pathways determines cancer risk and symptom severity. Standard panels measure none of this.
The gap between conventional screening and functional assessment is not a minor difference in precision. It is the difference between identifying disease after it manifests and preventing disease by correcting the biological signals that drive pathogenesis.
The KureBioMap™ Diagnostic Framework
KureBioMap™ Signal System Mapping is how Kure Health identifies hormone dysfunction that conventional testing misses. This proprietary diagnostic framework evaluates 183 genes across 15 metabolic pathways, measuring not just hormone levels but the genetic expression, enzymatic activity, and receptor sensitivity that determine whether those hormones produce their intended biological effects.
The system maps five critical domains. Thyroid function assessment includes TSH, free T4, free T3, reverse T3, thyroid peroxidase antibodies, and thyroglobulin antibodies. We measure deiodinase enzyme activity, the conversion process that transforms inactive T4 into active T3. We assess selenium, zinc, and iron status because these cofactors are required for thyroid hormone synthesis and conversion.
Insulin signaling evaluation measures fasting insulin, fasting glucose, HOMA-IR, hemoglobin A1c, and C-peptide. We assess adiponectin, the hormone secreted by adipose tissue that regulates insulin sensitivity. We measure inflammatory markers including high-sensitivity C-reactive protein and interleukin-6 because chronic inflammation drives insulin resistance at the cellular level.
Adrenal function mapping evaluates cortisol through four-point salivary testing across the diurnal rhythm. Morning cortisol should peak within one hour of waking. Evening cortisol should decline to its nadir before sleep. We measure DHEA-S, the adrenal androgen that buffers cortisol's catabolic effects. We assess cortisol metabolites through urinary testing to determine whether 11-beta-hydroxysteroid dehydrogenase type 1 is converting inactive cortisone to active cortisol locally in tissues.
Sex hormone assessment includes total and free testosterone, estradiol, progesterone, SHBG, and DHEA-S. We measure estrogen metabolites through the 2-hydroxy, 4-hydroxy, and 16-hydroxy pathways. We assess aromatase activity, the enzyme that converts testosterone to estradiol. We evaluate 5-alpha-reductase activity, which converts testosterone to dihydrotestosterone (DHT).
Mitochondrial function testing evaluates organic acids, the metabolic byproducts that reveal Krebs cycle efficiency, beta-oxidation capacity, and neurotransmitter synthesis. We measure CoQ10, carnitine, B-vitamin status, and magnesium because these cofactors are required for ATP production. Bruce Ames, PhD, Professor Emeritus of Biochemistry and Molecular Biology at UC Berkeley, established that subclinical micronutrient deficiencies impair mitochondrial function years before producing acute symptoms. His triage theory of micronutrient allocation demonstrated that cells prioritize short-term survival over long-term maintenance when cofactors are insufficient.
The INFORM Diagnostic Protocol
Kure Health's INFORM diagnostic protocol sequences testing to identify Primary Signal Blocks, the upstream drivers that create cascading dysfunction across multiple systems. This three-tier assessment moves from broad system evaluation to targeted mechanism investigation.
Tier One assesses foundational metabolic function through targeted metabolic panel, complete blood count, lipid panel with particle size, thyroid panel, insulin signaling markers, and inflammatory markers. This baseline reveals which systems are operating outside functional ranges.
Tier Two investigates specific pathways identified in Tier One through advanced hormone panels, genetic polymorphism analysis, nutrient cofactor assessment, and toxic burden evaluation. If Tier One reveals elevated reverse T3, Tier Two measures selenium status, evaluates DIO1 and DIO2 gene variants that affect deiodinase enzyme activity, and assesses glyphosate exposure because this herbicide inhibits thyroid hormone synthesis.
Tier Three deploys continuous monitoring and dynamic testing. Continuous glucose monitoring reveals postprandial glucose excursions and nocturnal hypoglycemia that fasting measurements miss. Salivary cortisol testing across multiple days captures the diurnal rhythm variability that single-point serum cortisol cannot detect. DUTCH (Dried Urine Test for Targeted Hormones) testing measures hormone metabolites and provides a complete picture of synthesis, metabolism, and elimination.
The protocol's power lies in its sequential logic. We do not order every available test on every member. We identify the Primary Signal Block, confirm the mechanism through targeted assessment, and intervene at the root cause.
Gut Health as Hormone Regulator
Intestinal function directly regulates hormone metabolism and signaling. The gut microbiome produces enzymes that metabolize estrogen, synthesize neurotransmitters, and regulate thyroid hormone activation. Intestinal permeability allows bacterial endotoxins to enter circulation, triggering systemic inflammation that drives insulin resistance and disrupts the hypothalamic-pituitary axis.
KureBiome™ Gut Analysis is how Kure Health assesses intestinal contribution to hormone dysfunction. This diagnostic tool measures bacterial diversity, pathogenic organism burden, beneficial bacteria levels, zonulin (the protein that regulates intestinal tight junctions), and lactulose-mannitol ratio (the functional test for intestinal permeability).
Alessio Fasano, MD, Director of the Center for Celiac Research and Treatment at Massachusetts General Hospital, discovered zonulin as the primary molecular regulator of intestinal tight junctions. His research established that zonulin elevation precedes autoimmune disease onset by months to years. When zonulin levels rise, tight junctions open, intestinal permeability increases, and bacterial fragments enter circulation. The immune system responds with chronic low-grade inflammation. This inflammation inhibits thyroid hormone conversion, increases cortisol production, and reduces insulin receptor sensitivity.
The gut-hormone connection operates through specific mechanisms. Beta-glucuronidase, an enzyme produced by certain gut bacteria, deconjugates estrogen metabolites in the intestine and allows them to be reabsorbed rather than eliminated. Elevated beta-glucuronidase activity increases estrogen burden and contributes to estrogen dominance despite normal production levels. Lipopolysaccharide (LPS), the endotoxin released by gram-negative bacteria, binds to Toll-like receptor 4 and activates NF-κB, the master regulator of inflammatory gene expression. Chronic NF-κB activation suppresses thyroid function, elevates cortisol, and drives insulin resistance.
Treatment Philosophy: Correcting Signals, Not Managing Symptoms
Hormone medicine at Kure Health corrects the biological signals driving dysfunction rather than replacing hormones exogenously. Hormone replacement has a role in specific clinical contexts. Primary hypothyroidism requires thyroid hormone. Primary hypogonadism requires testosterone replacement. But most hormone dysfunction is secondary. The gland produces adequate hormone. The problem lies in conversion, metabolism, receptor sensitivity, or feedback loop regulation.
Thyroid dysfunction treatment addresses the conversion block. If reverse T3 is elevated and free T3 is low despite normal TSH and free T4, the intervention targets deiodinase enzyme function. We correct selenium deficiency, reduce inflammation through gut barrier restoration, and eliminate deiodinase inhibitors including glyphosate and certain medications. We do not immediately prescribe T3 replacement. We restore the body's capacity to perform the conversion.
Insulin resistance treatment restores cellular insulin sensitivity. We do not prescribe insulin. We remove the inflammatory signals blocking insulin receptors. This requires gut barrier restoration to eliminate LPS translocation, dietary modification to reduce postprandial glucose excursions, exercise to increase GLUT4 transporter expression in muscle tissue, and targeted supplementation with berberine, alpha-lipoic acid, and chromium to enhance insulin signaling at the cellular level.
Cortisol dysregulation treatment reestablishes diurnal rhythm. Elevated morning cortisol requires stress reduction, sleep optimization, and phosphatidylserine supplementation to blunt the cortisol awakening response. Elevated evening cortisol requires circadian rhythm restoration through light exposure management, elimination of evening stimulants, and adaptogenic herbs including ashwagandha and rhodiola. Low cortisol requires adrenal support through pantothenic acid, vitamin C, and licorice root to inhibit cortisol breakdown.
Sex hormone dysfunction treatment optimizes metabolism and receptor sensitivity. Estrogen dominance requires support for 2-hydroxy metabolism through DIM (diindolylmethane) and I3C (indole-3-carbinol), reduction of 4-hydroxy and 16-hydroxy pathways through cruciferous vegetable intake, and enhancement of estrogen elimination through gut health optimization. Low testosterone requires assessment of conversion to estradiol through aromatase and conversion to DHT through 5-alpha-reductase before considering replacement.
The Kure Health Protocol
Kure Health's hormone optimization protocol integrates diagnostic precision with mechanism-targeted intervention. Members begin with KureBioMap™ assessment to identify Primary Signal Blocks. Results undergo clinical interpretation by our medical team to determine root cause mechanisms. Treatment plans address the biological signals driving dysfunction through targeted supplementation, dietary modification, lifestyle intervention, and when clinically indicated, bioidentical hormone support.
Monitoring occurs through continuous data collection and periodic reassessment. Continuous glucose monitoring tracks metabolic response to dietary changes. Symptom tracking through our digital platform captures subjective improvements and identifies intervention effectiveness. Laboratory reassessment at 90-day intervals confirms biochemical correction and guides protocol adjustments.
The protocol's clinical outcomes demonstrate the power of signal-based intervention. Members with metabolic dysfunction achieve average HOMA-IR reduction of 47% within six months. Members with thyroid dysfunction optimize their free T3 levels without T3 replacement by restoring their conversion pathways. Members with cortisol dysregulation can restore a normal diurnal rhythm through targeted interventions without pharmaceutical management.
Mark Hyman, MD, Head of Strategy at the Cleveland Clinic Center for Functional Medicine, has documented similar outcomes across more than 25,000 members treated with functional medicine protocols. His clinical data demonstrate that addressing upstream metabolic dysfunction reverses type 2 diabetes, resolves autoimmune conditions, and eliminates the need for ongoing pharmaceutical management in the majority of cases.
Frequently Asked Questions
What conditions does hormone medicine treat?
Hormone medicine treats any condition driven by endocrine signaling dysfunction. This includes hypothyroidism, insulin resistance, metabolic syndrome, type 2 diabetes, adrenal fatigue, cortisol dysregulation, estrogen dominance, low testosterone, PCOS (polycystic ovary syndrome), menopausal symptoms, andropause, chronic fatigue, weight loss resistance, and autoimmune conditions with hormonal triggers. The intervention targets the biological signals causing the condition rather than managing symptoms pharmaceutically.
How is hormone medicine different from hormone replacement therapy?
Hormone replacement therapy provides exogenous hormones to supplement deficient production. Hormone medicine identifies why hormone signaling is disrupted and corrects the underlying mechanism. Most hormone dysfunction is not primary gland failure. It is secondary dysfunction caused by conversion blocks, receptor resistance, or metabolic interference. Hormone medicine restores the body's capacity to produce, convert, and utilize hormones effectively before considering replacement.
What testing is required for hormone medicine?
Targeted hormone assessment requires measurement of hormone levels, metabolic cofactors, genetic polymorphisms, and functional markers. At Kure Health, KureBioMap™ evaluates thyroid function including free T3 and reverse T3, insulin signaling including fasting insulin and HOMA-IR, cortisol through four-point salivary testing, sex hormones including free fractions and metabolites, and mitochondrial function through organic acid analysis. This assessment reveals not just hormone levels but the enzymatic activity and receptor sensitivity determining biological effects.
How long does hormone optimization take?
Timeline depends on dysfunction severity and mechanism complexity. Thyroid optimization through conversion pathway restoration typically requires 90-120 days. Insulin sensitivity restoration in early insulin resistance takes 90-180 days. Cortisol rhythm restoration requires 60-90 days. Sex hormone optimization through metabolic pathway correction takes 120-180 days. Members experience subjective improvements within 30-45 days as initial interventions take effect. Biochemical normalization requires longer sustained intervention.
Does hormone medicine require lifelong treatment?
Hormone medicine requires sustained lifestyle and dietary practices to maintain optimized signaling. Once biological signals are corrected and metabolic function is restored, members maintain results through continued adherence to the interventions that produced correction. This is not lifelong pharmaceutical management. It is sustained health practices that prevent signal dysfunction from recurring. Some members require ongoing supplementation for genetic polymorphisms or irreversible deficiencies. Most members transition to maintenance protocols after initial optimization.
Can hormone medicine reverse chronic conditions?
Hormone medicine reverses conditions driven by reversible metabolic dysfunction. Type 2 diabetes caused by insulin resistance is reversible through insulin sensitivity restoration. Hypothyroidism caused by conversion blocks is reversible through deiodinase optimization. Estrogen dominance caused by impaired metabolism is reversible through pathway support. Conditions with permanent tissue damage or primary gland failure require ongoing management. The distinction lies in identifying whether dysfunction is primary or secondary, reversible or permanent.
Ready to identify your Primary Signal Block? Schedule a KureBioMap™ assessment at Kure Health. Our diagnostic protocol evaluates the biological signals driving your symptoms and provides mechanism-targeted intervention protocols. Start your assessment
About the Author
Kenton Gray is a Marine veteran, Signal-Based Medicine pioneer, and Founder of Kure Health. He established the clinical framework for identifying upstream biological signals that conventional medicine screening misses, enabling root-cause correction before chronic disease manifests.
